[Federal Register Volume 87, Number 182 (Wednesday, September 21, 2022)]
[Notices]
[Page 57707]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20436]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Fiscal Year (FY) 2022 Notice of Supplemental Funding Opportunity

AGENCY: Substance Abuse and Mental Health Services Administration, HHS.

ACTION: Notice of intent to award supplemental funding.

-----------------------------------------------------------------------

SUMMARY: This notice is to inform the public that the Substance Abuse 
and Mental Health Services Administration (SAMHSA) is supporting an 
administrative supplement (in scope of the parent award) up to $20,833 
(total costs) for one-year to the Improving Access to Overdose 
Treatment grant recipients for a total of up to $104,165 (total 
funding). These recipients were funded in FY 2018 with a project end 
date of September 30, 2023. The supplemental funding will be utilized 
specifically to increase the number of health care providers and 
pharmacists who receive training and technical assistance on the 
prescribing of drugs or devices approved or cleared under the FDA for 
emergency treatment of known or suspected opioid overdose.

FOR FURTHER INFORMATION CONTACT: Judith Ellis, Substance Abuse and 
Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 
20857, telephone (240) 276-2567; email: [email protected].

SUPPLEMENTARY INFORMATION: Awardees will further collaborations with 
healthcare providers and pharmacists to educate them on overdose 
dangers and standing orders for FDA-approved overdose reversal drugs to 
patients and individuals who support persons at high-risk for overdose.
    The required activities for this supplement are as follows:
     Increase use of SAMHSA's Opioid Overdose Prevention 
Toolkit as a guide to develop and implement a comprehensive prevention 
program to reduce the number of prescription drug/opioid overdose-
related deaths and adverse events among cases of known or suspected 
opioid overdose.
     Provide technical assistance to collaborating partner 
organizations and practitioners in the implementation of a 
comprehensive prevention program to reduce the number of prescription 
drug/opioid overdose-related deaths and adverse events.
     Collaborate with additional pharmacies to distribute drugs 
or devices approved or cleared under the Federal Food, Drug, and 
Cosmetic Act for emergency treatment of known or suspected opioid 
overdose, as permitted by state law.
     Provide targeted public education on the state's ``Good 
Samaritan'' laws related to a drug overdose, if applicable, such as 
those that permit bystanders to alert emergency responders to an 
overdose or to administer drugs or devices approved or cleared under 
the Federal Food, Drug, and Cosmetic Act for emergency treatment of 
known or suspected opioid overdose without fear of civil or criminal 
penalties.
    This is not a formal request for application. Assistance will only 
be provided to the Improving Access to Overdose Treatment Funding 
Opportunity SP-18-006 grant recipients based on the receipt of a 
satisfactory application and associated budget that is approved by a 
review group.
    Funding Opportunity Title: FY 2018 Improving Access to Overdose 
Treatment Funding Opportunity SP-18-006.
    Assistance Listing Number: 93.243.
    Authority: Section 516 of the Public Health Services Act, as 
amended.
    Justification: Eligibility for this supplemental funding is limited 
the Improving Access to Overdose Treatment Funding Opportunity SP-18-
006 grant recipients funded in FY 2018. These organizations are 
uniquely positioned to provide training and technical assistance to 
organizations and practitioners in prescription drug overdose 
prevention activities being funded through this supplement.

Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2022-20436 Filed 9-20-22; 8:45 am]
BILLING CODE 4162-20-P